Abstrakt: The efficacy of rituximab in patients with splenectomized refractory chronic ITP Posted on 30.10.2009 17:48
Topic: Trombocytopenia
The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura
Semir Pasa1, Abdullah Altintas1, Timucin Cil2, Ramazan Danis3 and Orhan Ayyildiz1
(1) Department of Hematology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
(2) Department of Oncology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
(3) Department of Nephrology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
J Thromb Thrombolysis (2009) 27:329-333
Keywords Refractory chronic idiopathic thrombocytopenic purpura - Splenectomy - Anti-CD20 monoclonal antibody - Rituximab
pozri abstrakt
|
|
| |
Ešte nemáte konto? Môžete si ho vytvoriť. Registrovaný užívateľ má niektoré výhody, napr. manažér tém, nastavenie komentárov a posielanie komentárov s vlastným menom. |
|
Priemerné skóre: 1 hlasov: 1
|
|
|